APOGEE ENTERPRISES INC
For the period ended Nov 25, 2023. Filed Jan 3, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Nov 25, 2023 · Filed Jan 3, 2024
APOG$48.05+5.0%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Cash Flows
| Nine Months Ended | ||
|---|---|---|
| (In thousands) | November 25, 2023 | November 26, 2022 |
| Operating Activities | ||
| Net earnings | $83,877 | $83,885 |
| Adjustments to reconcile net earnings to net cash provided by operating activities: | ||
| Depreciation and amortization | 31,185 | 31,925 |
| Share-based compensation | 6,644 | 5,961 |
| Deferred income taxes | 1,296 | 2,341 |
| Gain on disposal of assets | (50) | (1,484) |
| Proceeds from New Markets Tax Credit transaction, net of deferred costs | — | 18,390 |
| Settlement of New Markets Tax Credit transaction | (4,687) | (19,523) |
| Noncash lease expense | 8,742 | 8,924 |
| Other, net | 10 | 4,700 |
| Changes in operating assets and liabilities: | ||
| Receivables | (846) | (55,791) |
| Inventories | 8,256 | (5,822) |
| Contract assets | 11,194 | (8,314) |
| Accounts payable | (1,902) | (19,780) |
| Accrued expenses | (7,015) | 7,281 |
| Contract liabilities | 7,635 | 24,702 |
| Refundable and accrued income taxes | (7,587) | (14,391) |
| Operating lease liability | (9,214) | (9,168) |
| Prepaid expenses and other current assets | 1,714 | (2,724) |
| Net cash provided by operating activities | 129,252 | 51,112 |
| Investing Activities | ||
| Capital expenditures | (26,956) | (18,119) |
| Proceeds from sales of property, plant and equipment | 247 | 5,212 |
| Purchases of marketable securities | (969) | — |
| Sales/maturities of marketable securities | 1,370 | 923 |
| Net cash used by investing activities | (26,308) | (11,984) |
| Financing Activities | ||
| Borrowings on line of credit | 195,851 | 430,879 |
| Repayment on debt | — | (151,000) |
| Payments on line of credit | (265,000) | (239,000) |
| Payments on debt issuance costs | — | (790) |
| Repurchase and retirement of common stock | (11,821) | (74,312) |
| Dividends paid | (15,690) | (14,415) |
| Other, net | (3,781) | (2,959) |
| Net cash used by financing activities | (100,441) | (51,597) |
| Increase (decrease) in cash, cash equivalents and restricted cash | 2,503 | (12,469) |
| Effect of exchange rates on cash | (569) | 350 |
| Cash, cash equivalents and restricted cash at beginning of year | 21,473 | 37,583 |
| Cash and cash equivalents at end of period | $23,407 | $25,464 |
| Noncash Activity | ||
| Capital expenditures in accounts payable | $1,231 | $1,557 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.